Opportunity Information: Apply for RFA DA 23 009
The NIH funding opportunity "Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery" (RFA-DA-23-009) supports early-stage, exploratory research projects that test intervention approaches aimed at reducing loneliness and/or strengthening social connectedness as a way to prevent substance use, treat substance use disorders (SUDs), or improve recovery outcomes for people with SUDs. It uses the R21 mechanism, which is typically intended for pilot or proof-of-concept work that can generate preliminary evidence, refine methods, and set the stage for larger, more definitive studies later on. A key boundary in this announcement is that clinical trials are not allowed, meaning applicants need to design their projects so they do not meet the NIH definition of a clinical trial while still producing meaningful intervention-focused insights (for example, feasibility development, pilot testing components that do not involve prospective assignment to conditions to evaluate health outcomes, or other non-trial intervention research approaches consistent with NIH guidance).
The core idea behind the program is that social relationships and the subjective experience of loneliness are not just background factors, but potentially important drivers of substance use risk, SUD onset, relapse, and long-term recovery. NIH is looking for intervention projects that build directly on existing foundational and epidemiologic research on social connectedness and loneliness, and that help move the field toward a more coherent, unified theory explaining how these social factors influence substance use behaviors and SUD trajectories. In practical terms, proposals should not only test an approach, but also clarify mechanisms, pathways, or conceptual models that link social disconnection or connection to substance use and recovery processes.
Interventions can be designed for multiple levels of influence. Projects may focus on individuals (such as strategies to build social skills, increase supportive contacts, or reduce perceived isolation), dyads (for example, partner- or peer-based support approaches), families (such as strengthening family functioning or recovery-supportive communication), or broader community contexts. The announcement explicitly welcomes telehealth and technology-enabled delivery, which could include remote counseling or coaching, digitally supported peer networks, or other virtual modalities designed to reduce loneliness and increase supportive engagement. It also encourages community-level interventions that target structural or environmental conditions, recognizing that loneliness and disconnection are often shaped by social determinants of health. This means applicants can propose changes in policies, environments, or community infrastructures that make connection more accessible and sustainable, rather than placing the entire burden on individuals to "be more social."
The opportunity is intentionally broad about where these interventions might be implemented, reflecting the many places where people live, work, and seek support. Potential settings include workplaces, online or social media spaces, educational environments, housing contexts (including supportive or recovery housing), and recovery centers, among others. This flexibility opens the door to proposals that meet people where they are, including outside traditional healthcare environments, and that address real-world barriers to connection such as transportation, stigma, unstable housing, limited community resources, or lack of culturally relevant support.
Across all possible approaches, the program emphasizes user-centered research and real-world usefulness. NIH is signaling interest in solutions that are practical and implementable, not just theoretically interesting. Strong proposals are likely to prioritize acceptability to the intended population, feasibility in typical service settings, cost considerations, and the potential to scale and sustain the intervention beyond a single research site. The overall aim is to produce actionable knowledge and intervention strategies that can realistically reduce substance use and addiction harms by strengthening the social conditions that support prevention and recovery.
Administratively, this is a discretionary grant opportunity from the National Institutes of Health, listed under CFDA 93.279, with an original closing date of August 15, 2022, and a posting date of March 14, 2022. Eligible applicants span a wide range of organizations, including state, county, and local governments; public and private institutions of higher education; independent school districts; special district governments; federally recognized tribes and other tribal entities; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses. The announcement also highlights additional eligible applicant types such as faith-based and community-based organizations, minority-serving institutions (including HBCUs, Hispanic-serving institutions, AANAPISISs, Alaska Native and Native Hawaiian Serving Institutions, and Tribally Controlled Colleges and Universities), regional organizations, U.S. territories or possessions, eligible federal agencies, and even non-U.S. entities/foreign organizations. This broad eligibility aligns with the topic area, since effective connectedness and loneliness interventions often require partnerships across healthcare, community services, housing, education, and culturally specific community institutions.Apply for RFA DA 23 009
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2022-03-14.
- Applicants must submit their applications by 2022-08-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Small Business Innovation Research (SBIR) Program Phase II
Previous opportunity: Somatic Mosaicism across Human Tissues (SMaHT) Program: Organizational Center (U24 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 23 009
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 23 009) also looked into and applied for these:
| Funding Opportunity |
|---|
| Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R34 - Clinical Trial Optional) Apply for RFA DA 23 010 Funding Number: RFA DA 23 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Short-Term Research Education Experiences to Attract Talented Students to Biomedical Informatics/Data Science Careers and Enhance Diversity (R25 Clinical Trial Not Allowed) Apply for RFA LM 22 001 Funding Number: RFA LM 22 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $125,000 |
| NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 22 133 Funding Number: PAR 22 133 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 - Clinical Trial Not Allowed) Apply for RFA DA 23 004 Funding Number: RFA DA 23 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) Apply for RFA DA 23 014 Funding Number: RFA DA 23 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 22 017 Funding Number: RFA CA 22 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) Apply for PAR 22 126 Funding Number: PAR 22 126 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Focused Technology Research and Development (R01 Clinical Trial Not Allowed) Apply for PAR 22 127 Funding Number: PAR 22 127 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 22 023 Funding Number: RFA CA 22 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 22 024 Funding Number: RFA CA 22 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Apply for RFA CA 22 022 Funding Number: RFA CA 22 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) Apply for RFA CA 22 021 Funding Number: RFA CA 22 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 013 Funding Number: RFA CA 22 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed) Apply for RFA CA 22 012 Funding Number: RFA CA 22 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional) Apply for RFA DA 23 021 Funding Number: RFA DA 23 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 025 Funding Number: RFA AI 22 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional) Apply for PAR 22 145 Funding Number: PAR 22 145 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional) Apply for RFA CA 22 016 Funding Number: RFA CA 22 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) Apply for RFA CA 22 020 Funding Number: RFA CA 22 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 22 025 Funding Number: RFA CA 22 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: $2,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 23 009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
